Opinion/decision on a Paediatric investigation plan (PIP): Emgality, Galcanezumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Surgical and medical procedures, PIP number: EMA/PE/0000227737

Opinion/decision on a Paediatric investigation plan (PIP): Nilemdo, bempedoic acid (ETC-1002), decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Metabolism and nutrition disorders, PIP number: EMA/PE/0000238109

EMA/PE/0000241641

Opinion/decision on a Paediatric investigation plan (PIP): Aimovig, erenumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Surgical and medical procedures, PIP number: EMA/PE/0000242151

EMA/PE/0000243984

EMA/PE/0000242247

Opinion/decision on a Paediatric investigation plan (PIP): Enerzair Breezhaler, Indacaterol (acetate),mometasone (furoate),glycopyrronium bromide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Respiratory, thoracic and mediastinal disorders, PIP number: EMA/PE/0000244179

Timetable: Extension application - ATMP

Timetable: Extension application

Download website data in JSON data format